Biotechnology - Biotechnology, Oxford BioMedica

Filter

Popular Filters

Oxford BioMedica concludes novel ocular license deal with Sanofi

Oxford BioMedica concludes novel ocular license deal with Sanofi

17-02-2014

UK-based Oxford BioMedica has concluded the terms of the development and commercialization license agreement…

BiotechnologyLicensingOphthalmicsOxford BioMedicaUK

Oxford BioMedica gets US and French go-ahead to resume recruitment into ocular clinical trials

17-10-2013

Oxford BioMedica has received agreement from the US Food and Drug Administration and the French regulatory…

BiotechnologyEuropeOphthalmicsOxford BioMedicaRegulationResearch

Oxford BioMedica earns Pfizer milestone

28-08-2013

UK, gene-based biopharma company Oxford BioMedica (LSE: OXB) says it has received a $1 million milestone…

BiotechnologyFinancialOncologyOxford BioMedicaPF-06263507PfizerResearch

Oxford BioMedica to close US trial of TroVax due to "changing landscape"

12-10-2012

UK gene-based biopharma company Oxford BioMedica (LSE: OXB) says that it plans to close the Phase II…

BiotechnologyOncologyOxford BioMedicaResearchTroVaxVaccines

Oxford BioMedica in glaucoma R&D accord with Mayo Clinic

31-10-2011

UK-based Oxford BioMedica (LSE: OXB) has entered into an R&D collaboration with the USA’s Mayo Clinic…

BiotechnologyLicensingOphthalmicsOxford BioMedicaPharmaceuticalResearchSanofi

Back to top